Stock listing

Shenzhen:300347 Hangzhou Tigermed Consulting Co., Ltd. (泰格医药) 股价

Home listing (Shenzhen) of Hangzhou Tigermed Consulting Co., Ltd.

Follow Hangzhou Tigermed Consulting Co., Ltd. into a list and get an email when it puts out news.

Share price · SZSE:300347

¥44.30 CNY -1.67 (-3.6%)

Close on Nov 20, 2026

Past year -12.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
¥44.20 – ¥45.84 CNYNov 20, 2026
Volume
8.10M sharesNov 20, 2026
Market cap
¥32.53B CNYAt the close on Nov 20, 2026 · price × 734.2M shares outstanding
52-week range
¥35.57 – ¥67.85 CNYLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
¥692.8M CNYMedian day 11.21M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Hangzhou Tigermed Consulting Co., Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Shenzhen:300347 · Home¥44.30 CNY-1.67 (-3.6%)8,095,974¥45.41¥45.84¥44.20¥45.97Close on Nov 20, 2026
HKEX:3347$31.80 HKD-1.54 (-4.6%)824,200$33.30$33.30$31.38$33.34Close on Nov 20, 2026
OTC:HNGZY$4.06 USD-0.39 (-8.8%)250$4.06$4.06$4.06$4.45Close on Nov 20, 2026
Frankfurt:5HZ1€3.58 EUR-0.18 (-4.8%)—€3.62€3.62€3.58€3.76Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SZSE:300347 · CNY, adjusted for splits

DayCloseChange%OpenHighLowVolume
¥44.30-1.67-3.6%¥45.41¥45.84¥44.208,095,974
¥45.97-1.83-3.8%¥47.56¥47.80¥43.9018,685,886
¥47.80+0.84+1.8%¥46.95¥47.84¥46.396,542,171
¥46.96-0.92-1.9%¥47.20¥48.00¥46.766,678,748
¥47.88-1.03-2.1%¥48.91¥48.91¥47.168,948,423
¥48.91-0.75-1.5%¥49.51¥50.05¥48.6110,588,367
¥49.66-1.59-3.1%¥51.00¥51.39¥48.6410,457,437
¥51.25-0.020.0%¥52.15¥52.37¥50.906,023,217
¥51.27-0.34-0.7%¥52.00¥52.50¥51.036,203,064
¥51.61-2.26-4.2%¥52.34¥53.69¥51.519,188,919
¥53.870.000.0%¥53.76¥55.15¥53.3112,381,834
¥53.87+3.74+7.5%¥50.14¥54.09¥49.7014,752,200
¥50.13+0.47+0.9%¥49.70¥51.56¥48.3813,371,904
¥49.66-0.010.0%¥50.39¥50.63¥48.6111,147,109
¥49.67+1.48+3.1%¥48.40¥53.39¥47.7216,831,871
¥48.19-0.07-0.1%¥48.00¥49.07¥47.628,215,038
¥48.26+0.44+0.9%¥48.78¥49.12¥46.4214,775,035
¥47.82-2.29-4.6%¥50.90¥50.90¥47.827,120,081
¥50.11+1.31+2.7%¥48.80¥50.97¥48.619,737,456
¥48.80-0.86-1.7%¥49.28¥49.65¥46.2914,321,577
¥49.66-1.53-3.0%¥51.44¥51.86¥48.889,105,247
¥51.19-0.61-1.2%¥52.11¥52.68¥50.717,345,890
¥51.80+1.22+2.4%¥50.50¥52.18¥49.607,568,986
¥50.58+0.51+1.0%¥49.49¥51.28¥48.079,291,776
¥50.07-1.99-3.8%¥53.00¥54.48¥49.2812,543,170
¥52.06-1.01-1.9%¥52.80¥54.13¥51.549,517,899
¥53.07-1.25-2.3%¥54.10¥54.92¥53.026,636,408
¥54.32-1.76-3.1%¥55.13¥55.88¥53.649,605,392
¥56.08+0.90+1.6%¥55.01¥58.27¥55.0011,358,277
¥55.18-0.29-0.5%¥55.00¥55.65¥52.8011,282,043
¥55.47-2.93-5.0%¥58.05¥58.48¥55.1612,392,749
¥58.40+1.93+3.4%¥56.53¥59.66¥56.2014,242,334
¥56.47-0.33-0.6%¥56.83¥58.64¥56.299,636,905
¥56.80-0.010.0%¥56.90¥58.80¥56.459,527,672
¥56.81-1.69-2.9%¥57.92¥58.70¥56.797,923,318
¥58.50+0.66+1.1%¥57.76¥59.50¥57.599,940,776
¥57.84-1.15-1.9%¥58.81¥59.15¥57.5512,733,295
¥58.99+1.60+2.8%¥58.43¥59.88¥58.0016,307,210
¥57.39+0.38+0.7%¥57.01¥59.39¥56.6615,984,092
¥57.01+0.21+0.4%¥56.82¥58.13¥56.0013,814,937
¥56.80+0.99+1.8%¥55.61¥57.17¥55.0014,939,956
¥55.81-0.59-1.0%¥56.00¥56.49¥55.3211,394,403
¥56.40+3.60+6.8%¥53.00¥56.64¥52.8021,286,207
¥52.80-1.01-1.9%¥53.43¥53.78¥51.2213,340,631
¥53.81-0.87-1.6%¥54.66¥55.00¥53.0210,550,047
¥54.68+1.38+2.6%¥53.24¥55.90¥52.3222,962,049
¥53.30+4.04+8.2%¥49.27¥53.88¥48.8423,526,980
¥49.26-0.74-1.5%¥50.01¥50.02¥48.518,030,462
¥50.00-0.61-1.2%¥51.20¥51.20¥49.548,125,100
¥50.61+0.42+0.8%¥50.10¥50.99¥49.778,158,405
¥50.19-1.21-2.4%¥51.40¥51.86¥50.009,964,308
¥51.40-1.39-2.6%¥52.50¥52.61¥51.0612,415,948
¥52.79+2.94+5.9%¥49.64¥54.22¥49.0031,225,920
¥49.85-0.93-1.8%¥50.40¥51.36¥49.7511,061,378
¥50.78-0.07-0.1%¥50.60¥50.97¥49.6012,365,517
¥50.85-1.42-2.7%¥52.03¥53.00¥50.5513,337,499
¥52.27+3.11+6.3%¥49.40¥52.88¥48.6322,060,604
¥49.16-5.21-9.6%¥54.48¥54.78¥48.8031,975,422
¥54.37-1.15-2.1%¥54.00¥55.26¥52.7422,440,928
¥55.52+3.74+7.2%¥53.79¥57.97¥53.2049,375,527

Splits

4 splits since 2013 · SZSE:300347 · every price before a split is adjusted for it

DayRatioWhat
3-for-2Split
2-for-1Split
2-for-1Split
2-for-1Split
Ticker
Shenzhen:300347
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Shenzhen
Currency
CNY

What changed lately

Latest news

All Hangzhou Tigermed Consulting Co., Ltd. news

Hangzhou Tigermed Consulting Co., Ltd. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
3 in the last 12 months · 13 in all · newest Sep 4, 2026 · oldest 2020
Decks
16 decks · latest August 2026

Where Hangzhou Tigermed Consulting Co., Ltd. is listed

ListingExchangeCountryCurrency
Shenzhen:300347 泰格医药 · Home listing · This pageShenzhenChinaCNY
HKEX:3347 泰格醫藥HKEXHong KongHKD
LS Exchange:A2QALDLS ExchangeGermanyEUR
OTC:HNGZYOTCUnited StatesUSD
gettex:5HZ1gettexGermanyEUR
OTC:HTMDFOTCUnited StatesUSD
Dusseldorf:5HZ1DusseldorfGermanyEUR
Frankfurt:5HZ1FrankfurtGermanyEUR
Lang & Schwarz:A2QALDLang & SchwarzGermanyEUR
Munich:5HZ1MunichGermanyEUR

Valuation

EV/sales 4.2× against a median of 8.1×: 3rd lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
¥31.93B CNY
P/E
Loss
EV/sales
4.2×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
1.7×
Gross margin
26.2%
Operating margin
10.1%
Net margin
−5.3%
Debt to equity
0.1×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Hangzhou Tigermed Consulting Co., Ltd. Class A · SZSE:300347US$4.88BUS$4.79Bn/a4.2×n/a1.7×−5.3%0.1×n/a
Bachem Holding AG Class B · SIX:BANBUS$6.80BUS$6.99B38.4×8.4×29.7×4.0×21.4%0.1×n/a
10x Genomics, Inc. · NASDAQ:TXGUS$6.29BUS$5.79Bn/a9.4×n/a7.5×−10.8%0.1×2.34
Anthem Biosciences Limited · NSE:ANTHEMUS$5.78BUS$5.71B87.3×25.9×62.5×16.3×30.0%0.0×n/a
Caris Life Sciences, Inc. · NASDAQ:CAIUS$4.97BUS$4.60B51.7×4.4×28.3×7.8×9.2%0.6×1.90
DiaSorin S.p.A. · MIL:DIAUS$4.78BUS$4.60B28.0×3.5×11.7×2.8×13.0%0.0×n/a
GRAIL, Inc. · NASDAQ:GRALUS$4.46BUS$3.76Bn/a22.6×n/a1.8×−243.8%0.0×2.83
SAI Life Sciences Ltd. · NSE:SAILIFEUS$4.13BUS$4.13B106×17.0×58.1×15.4×16.1%0.0×n/a
BillionToOne, Inc. · NASDAQ:BLLNUS$3.83BUS$3.36B77.6×7.7×59.6×6.8×11.3%0.2×1.35
CareDx, Inc. · NASDAQ:CDNAUS$3.68BUS$3.43B28.6×6.9×n/a7.9×25.9%0.0×1.26
Tecan Group AG · SIX:TECNUS$3.50BUS$3.49Bn/a3.3×34.0×2.6×−12.5%0.2×n/a
Median of the othersUS$4.62BUS$4.36B51.7×8.1×34.0×7.1×12.2%0.1×1.90

Forecasts

Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
60.07 CNY · Analysts' mean
EPS, year to Dec 2026
0.73 · 2 analysts
Revenue, year to Dec 2026
7.89B · 8 analysts

Team and board

Officers

OfficerRole
Chengcheng YangSenior Vice President, Chief Financial Officer
Hao WuCo-President
Zengyu WenDirector, President
Bin Shan M.D.Senior Vice President, Chief Information Officer
Jinlian LiSenior Vice President, GM of China Innovative Drug Clinical Operations
Lihua ChenSenior Vice President, GM of the Biometrics BU
Meng SongVice President, Chief Technology Officer
Shuang MoVice President, Chief Compliance Officer
Sijia HuSenior Vice President, GM of SMO
Tianrong JiSenior Vice President, Chief Investment Officer
Xia ChenSenior Vice President, Chief Medical Officer
Yunjie(Shelley) GongSenior Vice President, Chief Quality Officer
Zhenyu DaiSenior Vice President, Head of BD
Xiaochun CaoCo-founder, Director, Chair of the Board Executive Committee
Xiaoping YeCo-founder, Chairman

Board

DirectorRole
Xiaoping YeCo-founder, Chairman
Xiaochun CaoCo-founder, Director, Chair of the Board Executive Committee
Zengyu WenDirector, President

Events

QuarterResultsShare move
Q3 2026Oct 29, 2026 · Before open−0.1%
Q2 2026Aug 28, 2026 · After close+5.9%
Q1 2026Apr 28, 2026 · Before open+2.7%
Q4 2025Mar 30, 2026 · Before open−1.4%
Q3 2025Oct 28, 2025 · Before open+0.3%
Q2 2025Aug 28, 2025 · Before open−0.2%
Q1 2025Apr 29, 2025+1.0%
Q4 2024Mar 27, 2025 · Before open+4.3%
Q3 2024Oct 29, 2024 · Before open−3.9%
Q2 2024Aug 28, 2024 · Before open+2.3%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 25, 2024 · After close+8.8%
Q4 2023Mar 28, 2024 · After close+1.7%
Q3 2023Oct 27, 2023 · After close+9.2%
Q2 2023Aug 25, 2023 · Before open−3.2%
Q1 2023Apr 25, 2023 · Before open−3.0%
Q4 2022Mar 28, 2023 · Before open−0.9%
Q3 2022Oct 25, 2022 · After close+12.4%
Q2 2022Aug 25, 2022 · Before open+3.2%
Q1 2022Apr 26, 2022 · Before open+0.9%
Q4 2021Mar 10, 2022 · Before open+2.9%

Open Events

Decks

DeckKindSlidesDate
H1 2026 Earnings PresentationEarnings34 slidesAugust 2026
FY2025 Earnings PresentationEarnings37 slidesMarch 2026
J.P. Morgan Healthcare Conference 2026Conference31 slidesJanuary 2026
H1 2025 Earnings PresentationEarnings33 slidesAugust 2025
FY2024 Earnings PresentationEarnings37 slidesMarch 2025
J.P. Morgan Healthcare Conference 2025Conference28 slidesJanuary 2025
H1 2024 Earnings PresentationEarnings32 slidesAugust 2024
FY2023 Earnings PresentationEarnings37 slidesMarch 2024
J.P. Morgan Healthcare Conference 2024Conference20 slidesJanuary 2024
H1 2023 Earnings PresentationEarnings31 slidesAugust 2023
All 16 decks
DeckKindSlidesDate
FY2022 Earnings PresentationEarnings35 slidesMarch 2023
H1 2022 Earnings PresentationEarnings31 slidesAugust 2022
FY2021 Earnings PresentationEarnings41 slidesMarch 2022
H1 2021 Earnings PresentationEarnings23 slidesAugust 2021
FY2020 Earnings PresentationEarnings26 slidesMarch 2021
H1 2020 Earnings PresentationEarnings22 slidesAugust 2020

Open Decks

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue6.83B6.60B7.38B7.09B5.21B3.19B2.80B2.30B1.69B1.17B
Cost of revenue4.96B4.36B4.54B4.28B2.94B1.68B1.50B1.31B962.6M727.9M
Gross profit1.87B2.24B2.85B2.81B2.27B1.51B1.30B991.7M724.4M446.7M
Research and development257.6M238.4M261.6M234.6M211.8M156.6M124.0M88.0M49.7M41.9M
Selling, general and administrative322.2M736.8M650.2M630.1M547.5M390.6M349.6M314.2M236.5M228.4M
Operating income666.6M664.4M2.49B2.58B3.70B2.22B1.08B595.9M416.8M198.9M
Depreciation and amortization326.7M324.1M305.7M284.8M188.9M144.7M43.3M61.2M32.6M36.6M
EBITDA993.3M988.6M2.79B2.87B3.89B2.37B1.13B657.1M449.4M235.5M
Interest expense90.6M146.3M124.1M89.3M27.7M51.4M41.3M19.9M12.5M10.1M
Income before tax1.00B664.5M2.49B2.59B3.68B2.22B1.09B606.1M431.2M212.1M
Income tax216.6M338.6M313.7M292.9M189.7M113.8M99.3M99.1M55.3M
Net income887.9M405.1M2.02B2.01B2.87B1.75B841.6M472.2M301.0M140.7M
Earnings per share, basic1.030.472.342.323.302.191.130.630.410.20

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.78B2.06B7.42B7.86B8.54B10.1B2.04B704.5M536.8M364.5M
Short-term investments59.5M74.9M42.1M24.9M29.2M26.0M68.8M587.4K76.0M174.5M
Receivables1.41B3.96B3.70B3.09B2.16B1.43B1.22B882.3M692.5M511.7M
Inventory41.5M32.0M23.4M22.2M6.10M4.72M1.21M518.9K14.0K59.9K
Current assets6.18B6.30B11.3B11.1B10.9B11.6B3.37B1.65B1.35B1.09B
Property, plant and equipment1.33B1.12B682.7M425.8M254.9M202.0M200.3M
Goodwill3.52B3.23B2.76B2.49B1.78B1.44B1.16B1.03B1.05B602.2M
Total assets28.4B28.7B29.7B27.4B23.7B19.5B7.57B4.68B3.58B2.39B
Accounts payable371.1M257.3M249.3M158.0M147.9M101.3M75.2M44.0M24.0M15.5M
Current liabilities2.84B3.66B4.14B3.73B2.41B1.14B1.81B1.26B733.2M435.8M
Long-term debt603.0M323.6M434.2M244.6M56.8M22.8M36.0M36.7M
Total debt2.63B2.83B2.58B899.2M279.0M1.04B712.8M259.9M190.9M
Total liabilities4.10B4.61B5.23B4.77B3.14B1.65B2.05B1.41B781.9M548.5M
Shareholders' equity21.0B20.7B21.0B19.6B18.1B16.1B4.23B2.84B2.49B1.63B
Shares outstanding861.0M863.0M864.9M865.5M871.0M799.0M744.8M749.5M740.1M703.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.12B1.10B1.15B1.36B1.42B998.7M527.6M522.2M315.0M191.9M
Capital spending-214.4M-356.6M-313.8M-448.6M-368.6M-156.5M-102.9M-91.7M-46.0M-61.7M
Free cash flow903.7M740.4M836.7M908.9M1.06B842.2M424.6M430.5M269.0M130.3M
Cash from investing-4.74B-1.53B-2.79B-2.78B-2.37B-638.2M-366.5M-846.4M-530.0M
Cash from financing-1.70B-7.81M809.3M-163.1M9.34B1.43B10.0M702.3M485.7M
Dividends paid-343.7M-642.2M-589.9M-432.5M-261.7M-271.3M-174.6M-126.6M-62.3M-59.1M
Share buybacks-270.9M-29.8M-426.6M-516.0M-4.01M-67.9M-248.1M
Change in cash-325.9M-5.35B-382.8M-595.7M-1.58B7.92B1.34B173.0M161.6M162.2M

Open Financials

Cap table

Built by 6ix from Hangzhou Tigermed Consulting Co., Ltd. Class A’s releases

Common shares
734,246,050
Fully diluted
734,246,050

Fully diluted

LineShares
Common shares734,246,050

Share count over time

CountShares
Nov 22, 2026734,246,050

Open Cap table

Shareholders

Register

HolderSharesAs of
JPMorgan Chase & Co.24.5MOct 27, 2026
2017 Eagle Holdings LLC14.6MFeb 7, 2024
F-J Sands Family I, LLC14.6MFeb 7, 2024
Sands Frank Melville Sr.9.85MJan 5, 2021
Sun Life Financial Inc.8.61MSep 1, 2026
Massachusetts Financial Services Company8.61MSep 1, 2026
Sun Life of Canada (U.S.) Financial Services Holdings, Inc.8.61MSep 1, 2026
Citigroup Inc.8.29MSep 21, 2026
兴证全球基金管理有限公司7.81MMay 14, 2026
Schroders Limited7.59MOct 27, 2026
All 12 holders
HolderSharesAs of
Ninety One UK Limited7.56MFeb 25, 2022
Norges Bank7.23MSep 15, 2026

Funds

HolderSharesValueAs of
MFS International New Discovery Fund7.66MUS$34.1MJun 30, 2026
MFS Emerging Markets Equity Fund7.44MUS$29.4MMay 31, 2026
Vanguard Emerging Markets Stock Index Fund2.88MUS$14.1MJul 31, 2026
Vanguard Total International Stock Index Fund2.83MUS$13.8MJul 31, 2026
iShares Core MSCI Emerging Markets ETF638KUS$2.52MMay 31, 2026
JPMorgan Emerging Markets Research Enhanced Equity Fund511KUS$2.56MJul 31, 2026
Emerging Markets Core Equity 2 Portfolio480KUS$2.31MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund439KUS$2.14MJul 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF431KUS$2.07MJun 30, 2026
Xtrackers Harvest CSI 300 China A-Shares ETF383KUS$1.51MMay 29, 2026
Show 50 holders
HolderSharesValueAs of
The Emerging Markets Small Cap Series344KUS$1.65MJul 31, 2026
Vanguard International Explorer Fund312KUS$1.5MJul 31, 2026
Schwab Emerging Markets Equity ETF240KUS$947KMay 31, 2026
T. Rowe Price China Evolution Equity Fund162KUS$778KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF146KUS$704KJul 31, 2026
iShares Core MSCI Total International Stock ETF137KUS$689KJul 31, 2026
Vanguard Total World Stock Index Fund132KUS$645KJul 31, 2026
JPMorgan ActiveBuilders Emerging Markets Equity ETF116KUS$559KJul 31, 2026
VanEck ChiNext ETF99,637US$479KJun 30, 2026
Nationwide International Small Cap Fund93,816US$452KJul 31, 2026
iShares MSCI China ETF85,669US$339KMay 31, 2026
iShares MSCI Emerging Markets ETF80,743US$319KMay 31, 2026
Dimensional Emerging Core Equity Market ETF73,900US$355KJul 31, 2026
KraneShares MSCI All China Health Care Index ETF67,680US$324KJun 30, 2026
Vanguard Emerging Markets Select Stock Fund63,511US$319KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF57,700US$278KJul 31, 2026
Fidelity Series Global ex U.S. Index Fund54,922US$276KJul 31, 2026
International Opportunities Fund44,751US$177KMay 31, 2026
Fidelity Emerging Markets Index Fund40,546US$203KJul 31, 2026
Vanguard ESG International Stock ETF39,232US$155KMay 31, 2026
State Street(R) SPDR(R) S&P(R) China ETF38,660US$183KJun 30, 2026
Emerging Markets Social Core Equity Portfolio36,800US$177KJul 31, 2026
JPMorgan Active China ETF35,500US$171KJul 31, 2026
MFS Emerging Markets Equity Portfolio32,622US$157KJun 30, 2026
iShares MSCI All Country Asia ex Japan ETF26,112US$131KJul 31, 2026
Nuveen Emerging Markets Equity Index Fund24,208US$122KJul 31, 2026
Avantis Emerging Markets Equity ETF23,800US$93,962May 31, 2026
Franklin FTSE China ETF21,204US$97,212Jun 30, 2026
World ex U.S. Core Equity Portfolio20,700US$99,454Jul 31, 2026
iShares MSCI China A ETF16,834US$84,438Jul 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF16,800US$80,812Jul 31, 2026
Fidelity Global ex U.S. Index Fund14,690US$72,062Jul 31, 2026
State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF13,433US$64,349Jun 30, 2026
Emerging Markets Sustainability Core 1 Portfolio13,100US$62,939Jul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio11,661US$55,863Jun 30, 2026
College Retirement Equities Fund - Total Global Stock Account9,626US$46,293Jun 30, 2026
Emerging Markets Equity Index Fund9,595US$46,098Jun 30, 2026
Fidelity SAI Emerging Markets Index Fund9,447US$47,395Jul 31, 2026
Global Atlantic BlackRock Disciplined International Core Portfolio6,620US$31,727Jun 30, 2026
BlackRock Balanced Portfolio5,609US$26,955Jun 30, 2026

This page holds 50 of 77 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bin Shan M.D.Senior Vice President, Chief Information Officer · Since at least Nov 6, 2026
Chengcheng YangSenior Vice President, Chief Financial Officer · Since at least Nov 6, 2026
Hao WuCo-President · Since at least Mar 27, 2025
Jinlian LiSenior Vice President, GM of China Innovative Drug Clinical Operations · Since at least Nov 6, 2026
Lihua ChenSenior Vice President, GM of the Biometrics BU · Since at least Nov 6, 2026
Meng SongVice President, Chief Technology Officer · Since at least Nov 6, 2026
Shuang MoVice President, Chief Compliance Officer · Since at least Nov 6, 2026
Sijia HuSenior Vice President, GM of SMO · Since at least Nov 6, 2026
Tianrong JiSenior Vice President, Chief Investment Officer · Since at least Nov 6, 2026
Xia ChenSenior Vice President, Chief Medical Officer · Since at least Nov 6, 2026
All 15 people
PersonSeat
Xiaochun CaoCo-founder, Director, Chair of the Board Executive Committee · Since at least Aug 28, 2026
Xiaoping YeCo-founder, Chairman · Since at least Aug 28, 2026
Yunjie(Shelley) GongSenior Vice President, Chief Quality Officer · Since at least Nov 6, 2026
Zengyu WenDirector, President · Since at least Sep 4, 2026
Zhenyu DaiSenior Vice President, Head of BD · Since at least Nov 6, 2026

Open People

Log in to ask 6ix AI your own questions about Hangzhou Tigermed Consulting Co., Ltd.